Date(s)

10 Sep 2024

Meeting type

Virtual

Organizer

Central and Eastern European Meeting on Viral Hepatitis and HIV 2024

Related Enduring Materials

Enduring Materials

The presentation videos and slides for speakers’ lectures are made available, provided that the speakers have granted us permission to do so.

CEE 2024 webinar - 16:00

Update on the Epidemiology of HIV and Hepatitis in Central and Eastern Europe

Deniz Gökengin, MD, PhD

Ege University, School of Medicine, Department of Infectious Diseases, Turkey

Slideset

Video

The Impact of Migration and Subtypes on HIV Prevention and Treatment in Europe

Miłosz Parczewski, MD, PhD

Pomeranian Medical University, Szczecin, Poland

Advances in PrEP: What Has Been Achieved? Which Challenges Remain?

Anca Streinu-Cercel, MD, PhD

National Institute of Infectious Diseases "Prof. Dr. Matei Bals", Romania

Slideset

Video

The Future of Long-acting ARV for HIV Prevention and Treatment in Europe

Jürgen Rockstroh, MD

University of Bonn, Germany

Slideset

Video

Case Presentation 1: Long Acting ART as Maintenance Therapy in People Living with HIV

David Jilich, MD, Ph.D

Hospital Na Bulovce, Czech Republic

Slideset

Video

State-of-the-Art: Hepatitis B and D in People Living with HIV

Mojca Matičič, MD, PhD

University of Ljubljana, Slovenia

Slideset

Video

Case Presentation 2: HepB/HepD Cirrhosis in a Patient Living with HIV

Stefan Cristian Malciolu, MD

Victor Babes Infectious and Tropical Diseases Hospital, Bucharest, Romania

Slideset

Video

Overview

Thank you

We are pleased to reflect on the highly successful webinar for the Central and Eastern European Meeting on Viral Hepatitis and HIV 2024.

The Program Chair and organizers would like to thank the speakers, chairs, and all participants for their contribution to this meeting!

Special thanks to the webinar support: Gilead. Without their contribution, this webinar would not have been made possible.

About this Program

The Central and Eastern European Meeting on Viral Hepatitis and HIV 2024 was held as a webinar.

This independent program was initiated in 2014 and has since been further developed by regional and international key opinion leaders for the medical and scientific community in Eastern and Central European countries. Given the rapid advancements in the treatment of HIV and viral hepatitis, it is imperative that clinicians and scientists stay informed about and discuss the upcoming region-specific challenges.

Program Chairs

Jürgen Rockstroh, MD

University of Bonn, Germany

Jonathan Schapiro, MD

National Hemophilia Center, Sheba Medical Center, Israel

General Information

Who Should Attend?

The target audience of this webinar consists of healthcare professionals involved in daily care for HCV patients such as infectious disease doctors, gastroenterologists, hepatologists, and others.

Meeting Objectives

This webinar aims to:

• Educate the practicing clinician on the best treatment options for viral hepatitis and HIV;

• Share state-of-the-art information and how it relates to daily clinical practice;

• Provide a Central and Eastern European platform for interaction and dialogue;

• Stimulate discussion among different disciplines; and

• Build collaborations and developing research activities.

Learning Objectives

After participating in this webinar, participants will be able to:

• Describe the spread of viral hepatitis and HIV in Central and Eastern Europe;

• Be updated on the latest developments in treatment strategies for hepatitis and HIV;

• Summarize the specific treatment and prevention challenges in Central and Eastern Europe;

• Identify and adjust treatment strategies in different patient populations;

• Update knowledge on the COVID-19 treatment and prevention options; and

• Comprehend impact of SARS-CoV2 infection on liver disease and HIV co-infection.

Practical Information

Certificate of Attendance

A certificate of attendance will be sent to participants who successfully complete the program and post-meeting survey.

Language

The official language of the meeting is English.

Disclaimer

This webinar is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this webinar, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this webinar. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the webinar.

Liability and Insurance

By registering for the webinar, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.

Photographs, Audio, and Video Recording

Photographs, audio, and video recordings are not permitted at the official webinar sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.

Code of Conduct

All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.

Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.

Committees

Program Chairs

Jürgen Rockstroh, MD

University of Bonn, Germany

Jonathan Schapiro, MD

National Hemophilia Center, Sheba Medical Center, Israel

Organizing Committee

Pavel Khaykin, MD

MainFachArzt Frankfurt, Germany

Mila Maistat

Medicines Patent Pool (MPP), Switzerland

Mojca Matičič, MD, PhD

University of Ljubljana, Slovenia

Miłosz Parczewski, MD, PhD

Pomeranian Medical University, Szczecin, Poland

Anca Streinu-Cercel, MD, PhD

National Institute of Infectious Diseases "Prof. Dr. Matei Bals", Romania

Adrian Streinu–Cercel, MD, PhD

National Institute of Infectious Diseases "Prof. Dr. Matei Bals", Romania

Cihan Yurdaydin, MD

Department of Gastroenterology and Hepatology, University Medical School, Istanbul, Turkey

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Support

Silver Level Sponsor

Support Our Initiative

Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and researchers interested in viral hepatitis and HIV.

This collaboration plays a vital role in both the organizational as well as scientific success of the program.

To show your commitment to the cause and get in touch with us for a tailored support package for CEE 2025, please contact Lara at lara.dasilvamiguel@amededu.com.

Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

Symposium opportunities
Non-commercial interviews with company representatives
Verbal acknowledgement during the program
Discounted and complimentary registrations for your representatives
Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
Company acknowledgement on printed meeting materials including but not limited to banners and the program book
Digital and printed advertising opportunities
Social media shout-outs
Logo on the conference bag

*Subject to the support level.

Accreditation

Central and Eastern European Meeting on Viral Hepatitis and HIV 2024 was accredited by the following society. To claim the CME points, members of the societies must either log on to the virtual congress portal, or sign up on the attendance sheet onsite, and attend the full sessions. Additional information such as membership number or license number might be required after the event.

European Accreditation Council for Continuing Medical Education (EACCME)

The Central and Eastern European Meeting on Viral Hepatitis and HIV 2024, Virtual, Netherlands 10/09/2024 - 10/09/2024, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 2.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Endorsers